Cargando…

Factors Influencing Drug Uptake during Mass Drug Administration for Control of Lymphatic Filariasis in Rural and Urban Tanzania

BACKGROUND: In most countries of Sub-Saharan Africa, control of lymphatic filariasis (LF) is based on annual mass drug administration (MDA) with a combination of ivermectin and albendazole. Treatment coverages are however often suboptimal for programmes to reach the goal of transmission interruption...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kisoka, William J., Simonsen, Paul E., Malecela, Mwelecele N., Tersbøl, Britt P., Mushi, Declare L., Meyrowitsch, Dan W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190414/ https://www.ncbi.nlm.nih.gov/pubmed/25296034 http://dx.doi.org/10.1371/journal.pone.0109316

Ejemplares similares

COMMUNITY MEMBERS' PERCEPTIONS OF MASS DRUG ADMINISTRATION FOR CONTROL OF LYMPHATIC FILARIASIS IN RURAL AND URBAN TANZANIA
por: KISOKA, WILLIAM J., et al.
Publicado: (2016)

Urban lymphatic filariasis in the metropolis of Dar es Salaam, Tanzania
por: Mwakitalu, Mbutolwe E, et al.
Publicado: (2013)

Lymphatic Filariasis Control in Tanzania: Effect of Repeated Mass Drug Administration with Ivermectin and Albendazole on Infection and Transmission
por: Simonsen, Paul E., et al.
Publicado: (2010)

Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration
por: Simonsen, Paul E, et al.
Publicado: (2014)

Lymphatic filariasis transmission in Rufiji District, southeastern Tanzania: infection status of the human population and mosquito vectors after twelve rounds of mass drug administration
por: Jones, Clarer, et al.
Publicado: (2018)

Lymphatic filariasis control in Tanzania: effect of six rounds of mass drug administration with ivermectin and albendazole on infection and transmission
por: Simonsen, Paul E, et al.
Publicado: (2013)

Lymphatic filariasis elimination efforts in Rufiji, southeastern Tanzania: decline in circulating filarial antigen prevalence in young school children after twelve rounds of mass drug administration and utilization of long-lasting insecticide-treated nets
por: Jones, Clarer, et al.
Publicado: (2017)

Lymphatic filariasis control in Tanzania: infection, disease perceptions and drug uptake patterns in an endemic community after multiple rounds of mass drug administration
por: Derua, Yahya A., et al.
Publicado: (2018)

Urban lymphatic filariasis
por: Simonsen, Paul E., et al.
Publicado: (2012)

Two decades of public health achievements in lymphatic filariasis (2000–2020): reflections, progress and future challenges
por: Malecela, Mwelecele, et al.
Publicado: (2020)

National Mass Drug Administration Costs for Lymphatic Filariasis Elimination
por: Goldman, Ann S., et al.
Publicado: (2007)

WILL MASS DRUG ADMINISTRATION ELIMINATE LYMPHATIC FILARIASIS? EVIDENCE FROM NORTHERN COASTAL TANZANIA
por: PARKER, MELISSA, et al.
Publicado: (2013)

Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania
por: Kroidl, Inge, et al.
Publicado: (2016)

Correction: Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania
por: Kroidl, Inge, et al.
Publicado: (2016)

Impact of Ivermectin Mass Drug Administration for Lymphatic Filariasis on Scabies in Eight Villages in Kongwa District, Tanzania
por: Martin, Diana, et al.
Publicado: (2018)

The role of gender relations in uptake of mass drug administration for lymphatic filariasis in Alor District, Indonesia
por: Krentel, Alison, et al.
Publicado: (2018)

Change in composition of the Anopheles gambiae complex and its possible implications for the transmission of malaria and lymphatic filariasis in north-eastern Tanzania
por: Derua, Yahya A, et al.
Publicado: (2012)

Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria
por: Pam, Dung D., et al.
Publicado: (2017)

Elimination of lymphatic filariasis: current perspectives on mass drug administration
por: Gyapong, John O, et al.
Publicado: (2018)

Impact of mass drug administration for elimination of lymphatic filariasis in Nepal
por: Ojha, Chet Raj, et al.
Publicado: (2017)

Experiences, opportunities and challenges of implementing task shifting in underserved remote settings: the case of Kongwa district, central Tanzania
por: Munga, Michael A, et al.
Publicado: (2012)

Lymphatic filariasis patient identification in a large urban area of Tanzania: An application of a community-led mHealth system
por: Mwingira, Upendo, et al.
Publicado: (2017)

No evidence of lymphatic filariasis transmission in Bamako urban setting after three mass drug administration rounds
por: Coulibaly, Yaya Ibrahim, et al.
Publicado: (2022)

Challenges in mass drug administration for treating lymphatic filariasis in Papua, Indonesia
por: Bhullar, Navneet, et al.
Publicado: (2010)

Factors determining noncompliance to mass drug administration for lymphatic filariasis elimination
por: Nujum, Zinia T, et al.
Publicado: (2012)

High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone
por: Hodges, Mary H, et al.
Publicado: (2010)

Correction to: No evidence of lymphatic filariasis transmission in Bamako urban setting after three mass drug administration rounds
por: Coulibaly, Yaya Ibrahim, et al.
Publicado: (2022)

Improving drug delivery strategies for lymphatic filariasis elimination in urban areas in Ghana
por: Biritwum, Nana-Kwadwo, et al.
Publicado: (2017)

Cessation of Mass Drug Administration for Lymphatic Filariasis in Zanzibar in 2006: Was Transmission Interrupted?
por: Rebollo, Maria P., et al.
Publicado: (2015)

Evaluation of mass drug administration in the program to control imported lymphatic filariasis in Thailand
por: Toothong, Tanaporn, et al.
Publicado: (2015)

The Health and Economic Burdens of Lymphatic Filariasis Prior to Mass Drug Administration Programs
por: Mathew, Christopher G, et al.
Publicado: (2020)

Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis
por: Alshehri, Abdullah, et al.
Publicado: (2023)

Increasing Coverage in Mass Drug Administration for Lymphatic Filariasis Elimination in an Urban Setting: a Study of Malindi Town, Kenya
por: Njomo, Doris W., et al.
Publicado: (2014)

Coverage of mass drug administration for elimination of lymphatic filariasis in urban Nagpur, Central India: A mixed method study
por: Banerjee, Sitikantha, et al.
Publicado: (2019)

Lymphatic filariasis elimination endgame in an urban Indian setting: the roles of surveillance and residual microfilaremia after mass drug administration
por: Modi, Anjali, et al.
Publicado: (2021)

Lymphatic filariasis, infection status in Culex quinquefasciatus and Anopheles species after six rounds of mass drug administration in Masasi District, Tanzania
por: Lupenza, Eliza, et al.
Publicado: (2021)

Safety and Tolerability of Ivermectin and Albendazole Mass Drug Administration in Lymphatic Filariasis Endemic Communities of Tanzania: A Cohort Event Monitoring Study
por: Fimbo, Adam M., et al.
Publicado: (2022)

Mass Drug Administration Coverage Evaluation Survey for Lymphatic Filariasis in Bagalkot and Gulbarga Districts
por: Patel, Prakash Kurubarahalli
Publicado: (2012)

Modeling the Impact and Costs of Semiannual Mass Drug Administration for Accelerated Elimination of Lymphatic Filariasis
por: Stolk, Wilma A., et al.
Publicado: (2013)

Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination
por: Alexander, Neal D. E.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qql6gsbc0arr5av92vu682re0a